Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells

Scandinavian Journal of Urology and Nephrology

Volumn 36, Issue 5, 2002, Pages 377-382

  Krishnamurthy, G ^a,b   Kher, Vijay ^a,c   Naik, Sita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c INDRAPRASTHA APOLLO HOSPITAL   (India)

Author keywords

Anti HBs antibody; B lymphocytes; Chronic renal failure; Hemodialysis; Immunoglobulin; Uremia

Indexed keywords

HEPATITIS B ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POKEWEED MITOGEN; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; UREMIA; VACCINATION;

ADULT; CASE-CONTROL STUDIES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KIDNEY FAILURE, CHRONIC; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; REFERENCE VALUES; RENAL DIALYSIS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 18744384323     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655902320783908     Document Type: Article

References (23)

1. Kher V, Bhawmick SK. Tuberculosis in renal failure - Role of vitamin D3. Ind J Nephrol 1992; 2: 29-31.
2. Chia S, Karim M, Elwood RK, FitzGerald JM. Risk of tuberculosis in dialysis patients: A population-based study. Int J Tuberc Lung Dis 1998; 2: 989-91.
3. Jha R, Kher V, Naik S, Elhence R, Gupta A, Sharma RK. Hepatitis B associated liver disease in dialysis patients: Role of vaccination. J Nephrol 1993; 6: 98.
4. Petrosillo N, Puro V, Ippolito G. Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients: The Italian multi centric study on nosocomial and occupational risk of blood-borne infections in dialysis. Nephron 1993; 64: 636.
5. Huang CC. Hepatitis in patients with end-stage renal disease. J Gastroenterol Hepatol 1997; 12: S236-41.
6. Chetanoud L, Herbelin A, Beauran G, Descamps Latscha B. Immune deficiency of the uremic patient. Adv Nephrol 1990; 19: 259-74.
7. Krishnamurthy G, Kher V, Naik Sita. Defective lymphoproliferative response and interleukin-2 production in chronic renal failure patients. Indian J Med Res 1995; 102: 281-6.
8. Haag-Weber M, Horl WH. Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol 1996; 16: 192-201.
9. Koziol-Montewka M, Ksiazek A, Majdan M, Spasiewicz D, Brydak L, Janicka L, et al. Influence of some immune factors on the IL-6 and soluble IL-2 receptors in hemodialysis patients. Int J Urol Nephrol 1997; 29: 369-75.
10. Borradori L, Born B, Descoeudres C, Skvaril F, Moreli A. Serum immunoglobulin levels and natural antibodies to Haemophilus influenzae in hemodialysis patients: Evidence for IgG subclass imbalance. Nephron 1990; 56: 35-9.
11. Kruger S, Seyfarth M, Sack K, Kreft B. Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination. Vaccine 1999; 17: 1145-50.
12. Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet 1992; 22: 434-46.
13. Degiannis D, Mowat AMCI, Galloway E, Tsakiris D, Briggs JD, Junor BJR, et al. In vitro analysis of B lymphocyte function in uremia. Clin Exp Immunol 1987; 70: 463-70.
14. Rasakova J, Ghobrial I, Czerwinski DK, Shea ST, Eisinger RP, Raska K. B cell activation and immuno-regulation in end-stage renal disease patients receiving hemodialysis. Arch Intern Med 1987; 147: 89-93.
15. Hoen B, Kessler M, Hestin D, Mayeux D. Risk factors for bacterial infections in chronic hemodialysis adult patients: A multicentre prospective survey. Nephrol Dial Transplant 1995; 10: 377-81.
16. Ifudu O, Brezsynyak WF, Reydel C, McClendon E, Surgrue T, DiRienzo R, et al. Pathobiology and functional status of long-term dialysis patients. Am J Nephrol 1995; 15: 379-85.
17. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, et al. Balance between IL-1β, TNF-α and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 1995; 154: 882-92.
18. Bird AG, Britton S, Ernberg I, Nilsson K. Characteristics of Epstein Barr virus activation of human B lymphocytes. J Exp Med 1981; 154: 832-8.
19. Gaciong Z, Alexiewicz JM, Linker-Israeli M, Shulman IA, Pitts TO, Massry SG. Inhibition of immunoglobulin production by parathyroid hormone. Implications for chronic renal failure. Kidney Int 1991; 40: 96-106.
20. Caillat-Zucman S, Giminez JJ, Albouze G, Lebkiri B, Naret C, Jungers P, et al. HLA genetic heterogeneity of hepatitis B vaccine response in hemodialysis patients. Kidney Int Suppl 1993; 43: S157-60.
21. Stachowski J, Poollock M, Barth C, Maciejewski J, Baldamus CA. Non-responsiveness to hepatitis B vaccination in hemodialysis patients: Association with impaired TCR/CD3 antigen receptor expression regulating co-stimulatory processes in antigen presentation and recognition. Nephrol Dial Transplant 1994; 9: 144-52.
22. Daichou Y, Kurashige S, Hashimoto S, Suzuki S. Characteristic cytokine products of TH1 and TH2 cells in hemodialysis patients. Nephron 1999; 83: 237-45.
23. Krishnamurthy G, Kher V, Naik S. Immunogenicity and efficacy of hepatitis B vaccination in Indian chronic renal failure patients on hemodialysis and after renal transplantation. Nephron 1996; 74: 424-5.